Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Pritchard, Kathleen
  • Thomssen, C
  • Pierga, J-Y
  • Cortes-Funes, H
  • Biganzoli, L
  • Guan, Z
  • Manikhas, G
  • Jendiroba, D
  • Uziely, B
  • Boyle, F
  • Jagiello-Gruszfeld, A
  • Van Arkel, C
  • Tung, Y
  • Dunne, A-A
  • Smith, IE

publication date

  • December 15, 2010